XML 42 R26.htm IDEA: XBRL DOCUMENT v3.24.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Stock-Based Compensation  
Schedule of stock option activity under all of the Company's equity incentive plans

    

    

    

    

Weighted

    

Weighted

Average

Shares

Number of

Average

Remaining

Aggregate

Available for

Shares

Exercise

Contractual

Intrinsic

Grant

Outstanding

Price

Life (Years)’

Value (000’s)

Outstanding as of January 1, 2022

 

216,003

 

8,799,415

$

3.07

 

8.12

 

$

60,924

2022 Equity incentive plan

5,000,000

Granted

 

(2,272,299)

 

2,272,299

 

3.26

 

 

Exercised

(395,235)

1.39

Forfeited

 

582,898

 

(582,898)

 

4.31

 

 

Expired

11,666

(11,666)

2.34

Outstanding as of December 31, 2022

 

3,538,268

 

10,081,915

$

3.11

 

7.61

$

4,099

2022 Equity incentive plan increase

1,917,456

Granted

 

(2,190,299)

 

2,190,299

 

1.01

 

 

Exercised

 

 

(451,020)

 

0.58

 

 

Forfeited

 

1,751,800

 

(1,751,800)

 

3.42

 

 

Expired

2022 Equity incentive plan decrease

(4,917,862)

Outstanding as of December 31, 2023

 

99,363

 

10,069,394

$

2.72

 

7.14

$

141

Vested and exercisable as of December 31, 2023

 

6,717,063

$

2.34

 

6.4

$

134

Schedule of assumptions utilized for option grants

    

Year Ended December 31, 

2023

    

2022

 

Risk-free interest rate

 

4.00

%  

7.33

%

Expected dividend yield

 

%  

%

Expected volatility

 

54.39

%  

54.60

%

Expected term (in years)

 

5.76

 

5.97

Schedule of stock-based compensation expense recognized in the Company's consolidated statements of operations

    

Year ended December 31, 

2023

    

2022

Cost of revenue, net

$

358

$

348

Research and development

 

397

 

1,058

Sales and marketing

 

221

 

235

General and Administrative

 

1,750

 

1,898

Total

$

2,726

$

3,539